Latest News - Corporate Lawsuits

Monday, August 17, 2015 | Corporate Lawsuits, Omeros

Omeros Announces Plan to File Infringement Suit Against ANDA Filer

Omeros today, in response to investor questions, announced that it plans to file a patent infringement lawsuit against Par Pharmaceutical and its subsidiary, Par Sterile Products, LLC, in response to …

Read the full story

Monday, August 17, 2015 | Corporate Lawsuits

Opternative Co-Founder Steven Lee, OD, Settles Lawsuit With National Board of Examiners in Optometry

Steven Lee, OD, co-founder and executive vice president of Opternative, the world’s first online refractive eye exam service, has settled a lawsuit alleging that he had sold copyrighted test que…

Read the full story

Monday, August 10, 2015 | Corporate Lawsuits

Judge Grants Relief to Amarin In Off-Label Case

A federal judge ruled that Amarin can now share unapproved off-label information about an FDA-approved drug as long as it is truthful and not misleading, a decision that bolsters the pharmaceutical in…

Read the full story

Wednesday, August 05, 2015 | Corporate Lawsuits, Akorn Pharmaceuticals, Allergan

Akorn Inc's Hi-Tech Pharmacal Infringes Allergan Glaucoma Drug Patents

An Akorn Inc unit's proposed generic glaucoma drug infringed three Allergan Inc patents on its Lumigan topical treatment for the eye disease, a U.S. appeals court ruled on Tuesday. The U.S. Court …

Read the full story

Thursday, June 18, 2015 | Corporate Lawsuits, Merck & Co. H

Merck to Pay $5.9 Million for Misleading Marketing of Pink Eye Drug

Merck & Co Inc has agreed to pay $5.9 million to resolve claims that a former unit fraudulently promoted a drug used to treat pink eye for unapproved purposes, US authorities announced on Wednesda…

Read the full story

Wednesday, April 15, 2015 | Corporate Lawsuits, Alcon

Virginia Company Alleges Alcon Stole Trade Secrets on Lens Technology

Elenza, a Roanoke, Va.-based medical device company, was on the verge of bringing new technology to market that would give millions of cataract sufferers complete visual range until one of its financi…

Read the full story

Thursday, October 16, 2014 | Corporate Lawsuits

ORA and SARcode Resolve Litigation

Ora and SARcode have resolved litigation concerning Ora's intellectual property and the parties have entered into a settlement agreement, according to a company news release. Terms of the settleme…

Read the full story

Thursday, September 25, 2014 | Corporate Lawsuits

James Mazzo, Ex-Advanced Medical Optics CEO, Indicted in Insider Case

Former Advanced Medical Optics Inc. Chief Executive Officer James Mazzo was charged with tipping a former Baltimore Orioles third baseman that his company was about to be acquired by Abbott Laboratori…

Read the full story

Wednesday, September 10, 2014 | Corporate Lawsuits

Oculentis Sues Lenstec and Lenstec (Barbados) for Patent Infringement

Oculentis IP BV issued proceedings against medical device company Lenstec Inc. and its subsidiary, Lenstec (Barbados) in the High Court of Justice in England claiming infringement of its UK patent (GB…

Read the full story

Wednesday, August 27, 2014 | Corporate Lawsuits

Allergan to Request California Federal Court Block Valeant and Pershing Square from Voting Shares Acquired in Violation of Insider Trading Laws

Allergan announced that it has asked the United States District Court for the Central District of California to set an expedited schedule for discovery and a motion for a preliminary injunction agains…

Read the full story

Friday, August 01, 2014 | Corporate Lawsuits

Allergan Sues Valeant and Pershing Square, Alleging Insider Trading Scheme

Allergan has filed a federal lawsuit against Valeant, Pershing Square Capital Management and its principal William Ackman, questioning the legality of the relationship between Valeant and the hedge fu…

Read the full story

Monday, June 30, 2014 | Corporate Lawsuits

Allergan Poison Pill Won’t Be Triggered by Pershing Call

Allergan Inc. agreed with Pershing Square Capital Management LP that a call for a special shareholder meeting to replace part of the drugmaker’s board won’t trigger a "poison pill" takeover defens…

Read the full story

Monday, June 16, 2014 | Corporate Lawsuits

Allergan ‘Pill’ Ruling Sought in $54 Billion Valeant Bid

Allergan's biggest investor, an affiliate of Pershing Square Capital Management LLP, asked a court to rule that its call for a special shareholder meeting to remove most of the drugmaker’s board won…

Read the full story

Thursday, June 05, 2014 | Corporate Lawsuits

Glaxo to Pay $105 Million to Settle Promotion Claims

GlaxoSmithKline Plc will pay $105 million to settle claims by California, New York and more than 40 other states that it illegally promoted asthma and antidepressant drugs. The accord announced today …

Read the full story

Tuesday, April 08, 2014 | Corporate Lawsuits

Takeda, Lilly Jury Awards $9 Billion Over Actos Risks

Takeda Pharmaceutical Co. (4502) and Eli Lilly & Co. (LLY) were ordered to pay a combined $9 billion in punitive damages after a federal court jury found they hid the cancer risks of their Actos d…

Read the full story
Load More